文献速递泌尿男性生殖肿瘤

前列腺癌大分割与常规分割放疗后患者报告功能结局:英格兰全国队列研究

Patient-Reported Functional Outcomes After Hypofractionated or Conventionally Fractionated Radiation for Prostate Cancer: A National Cohort Study in England.
PubMed 文献 · J Clin Oncol · 2020-01-02

该全国队列研究纳入2014年4月至2016年9月英格兰NHS诊断的前列腺癌男性,比较接受中度大分割放疗(H-RT)与常规分割放疗(C-RT)的患者报告功能结局。H-RT与性功能(3.3分;95%CI 2.1-4.5;P<.001)和激素功能(3.2分;95%CI 1.8-4.6;P<.001)小幅升高相关,但未达临床意义阈值,泌尿、肠道功能及生活质量无显著差异。

要点

  • H-RT与性功能和激素功能评分小幅升高相关,但未达临床意义阈值。
  • 泌尿功能、肠道功能及生活质量在H-RT与C-RT间无统计学显著差异。
  • 真实世界结果支持H-RT作为非转移性前列腺癌放疗标准。

核心结论

  • H-RT与C-RT在患者报告泌尿、肠道功能及生活质量上无显著差异,性功能和激素功能小幅升高但未达临床意义阈值。

研究设计与样本

  • 全国队列研究,纳入2014年4月至2016年9月英格兰NHS诊断的前列腺癌男性,诊断后至少18个月邮寄问卷。
  • 队列共17,058人,应答率77%;C-RT组8,432人(64.2%),H-RT组4,699人(35.8%)。

主要发现

  • H-RT组年龄≥70岁者占67.5%,C-RT组为60.9%。
  • H-RT组局部晚期患者占56.5%,C-RT组为71.3%。
  • H-RT组接受雄激素剥夺治疗者占79.5%,C-RT组为87.8%。
  • H-RT组治疗前泌尿生殖系统操作者占24.2%,C-RT组为21.2%。
  • 调整后H-RT与性功能评分升高3.3分(95%CI 2.1-4.5;P<.001)和激素功能评分升高3.2分(95%CI 1.8-4.6;P<.001)相关。

关键数值与推荐

  • EPIC-26各领域评分范围0-100分,评分越高代表结局越好。
  • EQ-5D-5L评分范围0-1分,评分越高代表结局越好。
  • 性功能和激素功能差异未达已建立的临床意义变化阈值。

临床怎么用

  • 真实世界数据支持将H-RT作为非转移性前列腺癌放疗标准。
  • 临床决策时可告知患者H-RT与C-RT在泌尿、肠道功能及生活质量上无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of the current study was to determine patient-reported functional outcomes in men with prostate cancer (PCa) undergoing moderately hypofractionated (H-RT) or conventionally fractionated radiation therapy (C-RT) in a national cohort study. PATIENDS AND METHODS: All men diagnosed with PCa between April 2014 and September 2016 in the English National Health Service undergoing C-RT or H-RT were identified in the National Prostate Cancer Audit and mailed a questionnaire at least 18 months after diagnosis. We estimated differences in patient-reported urinary, bowel, sexual, and hormonal function-Expanded Prostate Cancer Index Composite short-form 26 domain scores on a 0 to 100 scale-and health-related quality of life-EQ-5D-5L on a 0 to 1 scale-using linear regression with adjustment for patient, tumor, and treatment-related factors in addition to GI and genitourinary baseline function, with higher scores representing better outcomes. RESULTS: Of the 17,058 men in the cohort, 77% responded: 8,432 men received C-RT (64.2%) and 4,699 H-RT (35.8%). Men in the H-RT group were older (age ≥ 70 years: 67.5% v 60.9%), fewer men had locally advanced disease (56.5% v 71.3%), were less likely to receive androgen-deprivation therapy (79.5% v 87.8%), and slightly more men had pretreatment genitourinary procedures (24.2% v 21.2%). H-RT was associated with small increases in adjusted mean Expanded Prostate Cancer Index Composite short-form 26 sexual (3.3 points; 95% CI, 2.1 to 4.5; P < .001) and hormonal function scores (3.2 points; 95% CI, 1.8 to 4.6; P < .001). These differences failed to meet established thresholds for a clinically meaningful change. There were no statistically significant differences in urinary or bowel function and quality of life. CONCLUSION: This is the first national cohort study comparing functional outcomes after H-RT and C-RT reported by patients. These real-world results further support the use of H-RT as the standard for radiation therapy in men with nonmetastatic PCa.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Nossiter J, Sujenthiran A, Cowling TE, et al. Patient-Reported Functional Outcomes After Hypofractionated or Conventionally Fractionated Radiation for Prostate Cancer: A National Cohort Study in England. J Clin Oncol. 2020. PMID: 31895608. doi:10.1200/JCO.19.01538

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。